FDA approves new treatment for Type 2 diabetes

Posted by Food and Drug Administration--Press Releases on Monday May 2, 2011 Under News

The U.S. Food and Drug Administration today approved Tradjenta (linagliptin) tablets, used with diet and exercise, to improve blood glucose control in adults with Type 2 diabetes.

Be Sociable, Share!

Comments are closed.